Cargando…
Corrigendum to “Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity” [Mol. Cell Endocrinol. 440 (2016) 138–150]
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
North Holland Publishing
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854450/ https://www.ncbi.nlm.nih.gov/pubmed/28183459 http://dx.doi.org/10.1016/j.mce.2017.01.048 |
| _version_ | 1783470216585412608 |
|---|---|
| author | Nelson, A.W. Groen, A.J. Miller, J.L. Warren, A.Y. Holmes, K.A. Tarulli, G.A. Tilley, W.D. Katzenellenbogen, B.S. Hawse, J.R. Gnanapragasam, V.J. Carroll, J.S. |
| author_facet | Nelson, A.W. Groen, A.J. Miller, J.L. Warren, A.Y. Holmes, K.A. Tarulli, G.A. Tilley, W.D. Katzenellenbogen, B.S. Hawse, J.R. Gnanapragasam, V.J. Carroll, J.S. |
| author_sort | Nelson, A.W. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6854450 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | North Holland Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-68544502019-11-20 Corrigendum to “Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity” [Mol. Cell Endocrinol. 440 (2016) 138–150] Nelson, A.W. Groen, A.J. Miller, J.L. Warren, A.Y. Holmes, K.A. Tarulli, G.A. Tilley, W.D. Katzenellenbogen, B.S. Hawse, J.R. Gnanapragasam, V.J. Carroll, J.S. Mol Cell Endocrinol Corrigendum North Holland Publishing 2017-03-05 /pmc/articles/PMC6854450/ /pubmed/28183459 http://dx.doi.org/10.1016/j.mce.2017.01.048 Text en http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Corrigendum Nelson, A.W. Groen, A.J. Miller, J.L. Warren, A.Y. Holmes, K.A. Tarulli, G.A. Tilley, W.D. Katzenellenbogen, B.S. Hawse, J.R. Gnanapragasam, V.J. Carroll, J.S. Corrigendum to “Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity” [Mol. Cell Endocrinol. 440 (2016) 138–150] |
| title | Corrigendum to “Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity” [Mol. Cell Endocrinol. 440 (2016) 138–150] |
| title_full | Corrigendum to “Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity” [Mol. Cell Endocrinol. 440 (2016) 138–150] |
| title_fullStr | Corrigendum to “Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity” [Mol. Cell Endocrinol. 440 (2016) 138–150] |
| title_full_unstemmed | Corrigendum to “Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity” [Mol. Cell Endocrinol. 440 (2016) 138–150] |
| title_short | Corrigendum to “Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity” [Mol. Cell Endocrinol. 440 (2016) 138–150] |
| title_sort | corrigendum to “comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity” [mol. cell endocrinol. 440 (2016) 138–150] |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854450/ https://www.ncbi.nlm.nih.gov/pubmed/28183459 http://dx.doi.org/10.1016/j.mce.2017.01.048 |
| work_keys_str_mv | AT nelsonaw corrigendumtocomprehensiveassessmentofestrogenreceptorbetaantibodiesincancercelllinemodelsandtissuerevealscriticallimitationsinreagentspecificitymolcellendocrinol4402016138150 AT groenaj corrigendumtocomprehensiveassessmentofestrogenreceptorbetaantibodiesincancercelllinemodelsandtissuerevealscriticallimitationsinreagentspecificitymolcellendocrinol4402016138150 AT millerjl corrigendumtocomprehensiveassessmentofestrogenreceptorbetaantibodiesincancercelllinemodelsandtissuerevealscriticallimitationsinreagentspecificitymolcellendocrinol4402016138150 AT warrenay corrigendumtocomprehensiveassessmentofestrogenreceptorbetaantibodiesincancercelllinemodelsandtissuerevealscriticallimitationsinreagentspecificitymolcellendocrinol4402016138150 AT holmeska corrigendumtocomprehensiveassessmentofestrogenreceptorbetaantibodiesincancercelllinemodelsandtissuerevealscriticallimitationsinreagentspecificitymolcellendocrinol4402016138150 AT tarulliga corrigendumtocomprehensiveassessmentofestrogenreceptorbetaantibodiesincancercelllinemodelsandtissuerevealscriticallimitationsinreagentspecificitymolcellendocrinol4402016138150 AT tilleywd corrigendumtocomprehensiveassessmentofestrogenreceptorbetaantibodiesincancercelllinemodelsandtissuerevealscriticallimitationsinreagentspecificitymolcellendocrinol4402016138150 AT katzenellenbogenbs corrigendumtocomprehensiveassessmentofestrogenreceptorbetaantibodiesincancercelllinemodelsandtissuerevealscriticallimitationsinreagentspecificitymolcellendocrinol4402016138150 AT hawsejr corrigendumtocomprehensiveassessmentofestrogenreceptorbetaantibodiesincancercelllinemodelsandtissuerevealscriticallimitationsinreagentspecificitymolcellendocrinol4402016138150 AT gnanapragasamvj corrigendumtocomprehensiveassessmentofestrogenreceptorbetaantibodiesincancercelllinemodelsandtissuerevealscriticallimitationsinreagentspecificitymolcellendocrinol4402016138150 AT carrolljs corrigendumtocomprehensiveassessmentofestrogenreceptorbetaantibodiesincancercelllinemodelsandtissuerevealscriticallimitationsinreagentspecificitymolcellendocrinol4402016138150 |